<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04860193</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-04-14</org_study_id>
    <nct_id>NCT04860193</nct_id>
  </id_info>
  <brief_title>Audio Vestibular Functions in COVID 19 Patients in Sohag Governate</brief_title>
  <official_title>Audiovestibular Functions in Covid 19 Patients in Sohag Governate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is evidence that up to 30% of COVID-19 patients was reported with neurological&#xD;
      manifestations such as impaired consciousness, headache, and dizziness have been reported in&#xD;
      COVID-19 patients in addition, olfactory and taste alterations are common symptoms in&#xD;
      patients affected by COVID-19.This study will be conducted to evaluate the effect of the&#xD;
      novel coronavirus on audio-vestibular functions in confirmed COVID19 patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Basic audiological evaluation:</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Pure-tone audiometry.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Basic audiological evaluation:</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Acoustic immittance testing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Basic audiological evaluation:</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Speech audiometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Auditory evoked potentials:</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Auditory brainstem response.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Auditory evoked potentials</measure>
    <time_frame>3 months after infection</time_frame>
    <description>P300</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect on vestibular functions</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Videonystagmography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect on vestibular functions</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Video Head Implus test VHIT.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect on vestibular functions</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Vestibular evoked myogenic potential.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect on vestibular functions</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Computerized Dynamic Posturography (CDP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect on cognitive functions</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Cognitive function assessment:&#xD;
By Montreal test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vestibular questionnaire</measure>
    <time_frame>3 months after infection</time_frame>
    <description>Dizziness Handicap Inventory (DHI).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>COVID19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The present study will include 100 of randomly selected patients who were had been&#xD;
        confirmed to be infection with COVID 19 virus, age ranged from 20-50 years. The&#xD;
        investigation will be done three months after infection and after being sure that the&#xD;
        patient become noninfectious.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Well educated patients Age: range between 20 to 50 years No previous history of hearing&#xD;
        loss or otoneurologic disease&#xD;
&#xD;
        Well confirmed COVID 19 patients:&#xD;
&#xD;
        patients who were diagnosed with coronavirus from&#xD;
&#xD;
          -  symptoms: fever, cough, generalized malaise, dyspnea.&#xD;
&#xD;
          -  Laboratory finding: abnormalities have been observed in Complete blood count (CBC),&#xD;
             high C-reactive protein and ferritin, elevated D-dimer.&#xD;
&#xD;
          -  Imaging: Chest CT scan: bilateral ground glass opacities, crazy paving, and&#xD;
             consolidation.&#xD;
&#xD;
          -  nasopharyngeal swab for SARS-CoV-2 polymerase chain reaction testing (RT-PCR).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous history of hearing loss or otoneurological disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasmeen Mohamed</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Yasmeen Mohamed</last_name>
    <phone>01019774326</phone>
    <email>emadrashad150150@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sohag faculty of medicine</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Yasmeen Mohamed</last_name>
      <phone>01019774326</phone>
      <email>emadrashad150150@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 18, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Yasmeen Ali Mohamed</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

